Gene Editing & Health Insurance: Who Covers CRISPR Risks in 2025?
The CRISPR Insurance Dilemma As gene therapies enter mainstream medicine, insurers face unprecedented challenges:✔ $2M+ per treatment cost✔ Unknown long-term effects of DNA modifications✔ Ethical exclusions in standard policies Current Insurance Landscape for Gene Editing **1. Coverage Availability Therapy Type Insurer Stance Example Cases FDA-Approved CRISPR Treatments (e.g., Sickle Cell) 80% coverage with pre-auth Blue Cross, UnitedHealthcare Experimental Trials Limited to 50% with … Read more